Biogen Cuts the Price Tag on Its Alzheimer's Drug in Half
Biogen is slashing the price of its Alzheimer’s treatment months after the drug debuted to widespread criticism for an initial cost that can reach $56,000...
Stay updated with breaking news from Aduhelm. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biogen is slashing the price of its Alzheimer’s treatment months after the drug debuted to widespread criticism for an initial cost that can reach $56,000...
In the first six months of its launch, Biogen's Alzheimer's drug Aduhelm has disappointed Wall Street and been rejected by European regulators.
As of January 1, 2022, Biogen will cut the price of its Alzheimer’s drug Aduhelm (aducanumab-avwa) in half: saying too many patients are not currently being offered the choice of the drug due to financial considerations.
Biogen is slashing the price of its Alzheimer’s treatment in half months after it...
Biogen is slashing the price of its Alzheimer’s treatment in half months after it...